Table 2

Rodent-associated Bartonella Febrile Illness, Southwestern United States

Jonathan Iralu*, Ying Bai†, Larry Crook*, Bruce Tempest*, Gary Simpson‡, Taylor McKenzie§, and Frederick Koster¶#

Author affiliations: *US Public Health Service, Gallup, New Mexico, USA; †University of Colorado, Boulder, Colorado, USA; ‡New Mexico Department of Health, Santa Fe, New Mexico, USA; §The Navajo Nation, Window Rock, Arizona, USA; ¶University of New Mexico Health Science Center, Albuquerque, New Mexico, USA; #Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA

Main Article

Clinical and laboratory data of 5 adults with undifferentiated fever and seroconversion to Neotoma albigula–derived Bartonella antigens*

Patient no., age (y), sex	DOI	T (°C)†	Leukocytes × 10³/μL‡	PLT × 10³/μL‡	HCT (%)†	AST (U/L)†	BIL (mg/dL)†	LDH (U/L)†	Doubling dilution end titer (acute/convalescent phases)§
Patient no., age (y), sex	DOI	T (°C)†	Leukocytes × 10³/μL‡	PLT × 10³/μL‡	HCT (%)†	AST (U/L)†	BIL (mg/dL)†	LDH (U/L)†	Bartonella from Neotoma	B. vinsonii from Microtus pennsylvanicus	B. quintana	B. henselae	B. elizabethae
1, 55, F	5	39.7	2.7	147	44	183	1.5	167	256/4,096	64/64	<32/64	<32/<32	64/64
2, 30, M	5	39.3	3.2	110	50	85	1.5	206	256/1,024	128/1,024	64/512	64/256	64/512
3, 34, F	6	39.7	3.5	95	44	324	1.7	190	<32/1,024	<32/256	<32/64	64/256	<32/64
4, 29, M	2	39.2	17.9	226	48	ND	ND	ND	<32/512	32/64	<32/<32	<32/<32	32/32
5, 23, F	2	38.8	5.0	125	40	ND	ND	130	32/512	<32/64	<32/<32	<32/128	<32/64

*DOI, day of symptomatic illness at hospitalization; T, temperature; PLT, platelet count; HCT, hematocrit ; AST, aspartate aminotransferase; BIL, bilirubin; LDH, lactate dehydrogenase; ND, not determined.
†Highest value during 2–6 d of hospitalization.
‡Minimum value.
§Convalescent-phase titers 2–6 wk after hospital admission.

Main Article

Page created: December 16, 2011

Page updated: December 16, 2011

Page reviewed: December 16, 2011

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.